Literature DB >> 19255160

Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles.

Jing-Xia Liu1, Hugh J Willison, Fatima Pedrosa-Domellöf.   

Abstract

PURPOSE: To examine the distribution of anti-GQ1b, -GT1a, and -GD1b antibody binding in human extraocular muscles (EOMs), axial and limb muscles, and muscle spindles and thereby test the hypothesis that their distinctive ganglioside composition provides the molecular basis for selective involvement of EOMs and muscle spindles in Miller Fisher syndrome.
METHODS: Muscle samples from adult human EOMs, vastus lateralis, biceps brachii, lumbrical, psoas, and deep muscles of the neck were processed for immunohistochemistry, with monoclonal antibodies against ganglioside GQ1b, GT1a, and GD1b. Neuromuscular junctions (NMJs) were detected by alpha-bungarotoxin binding and by acetyl cholinesterase reaction.
RESULTS: Most motor endplates of human EOMs richly bound anti-GQ1b, -GT1a, and -GD1b ganglioside antibodies. Anti-GQ1b, -GT1a, and -GD1b ganglioside antibody bindings to NMJs in human limb and axial muscle were scarce, but the nerve terminals inside muscle spindles and in direct contact with intrafusal fibers were labeled with anti- GQ1b, -GT1a, and -GD1b ganglioside antibodies.
CONCLUSIONS: The abundant and synaptic-specific binding of anti-GQ1b, -GT1a, and -GD1b ganglioside antibodies and the rich capillary supply in the human EOMs may partly explain the selective paralysis of these muscles in Miller Fisher syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255160     DOI: 10.1167/iovs.08-3333

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  28 in total

1.  Fisher syndrome.

Authors:  Masahiro Mori; Satoshi Kuwabara
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.598

2.  GD1b-specific antibodies may bind to complex of GQ1b and GM1, causing ataxia.

Authors:  Nobuhiro Yuki; Yuki Fukami; Chiaki Yanaka; Saiko Koike; Koichi Hirata
Journal:  J Neurol       Date:  2014-05-25       Impact factor: 4.849

3.  The Role of Botulinum Toxin in the Management of Ophthalmoplegia Secondary to Miller Fisher Syndrome.

Authors:  Siegfried K Wagner; Nabil Uddin; Saurabh Jain
Journal:  Neuroophthalmology       Date:  2017-08-18

Review 4.  Neuro-ophthalmology and the Anti-GQ1b antibody syndromes.

Authors:  Robert F Saul
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

Review 5.  Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.

Authors:  Jaap J Plomp; Hugh J Willison
Journal:  J Physiol       Date:  2009-06-29       Impact factor: 5.182

Review 6.  Immunotherapy of Guillain-Barré syndrome.

Authors:  Shuang Liu; Chaoling Dong; Eroboghene Ekamereno Ubogu
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

7.  A pediatric case of Miller Fisher syndrome with central involvement.

Authors:  D Ajena; S Ferrari; S Romito; F Zaglia; P Biban; G Squintani
Journal:  Neurol Sci       Date:  2012-11-30       Impact factor: 3.307

Review 8.  Sustained response to subcutaneous immunoglobulins in chronic ataxic neuropathy with anti-disialosyl IgM antibodies (CANDA): report of two cases and review of the literature.

Authors:  D Marastoni; L Africa; G M Fabrizi; F Giannini; A Peretti; S Bocci; L Insana; S Ferrari; F Ginanneschi; G Zanette
Journal:  J Neurol       Date:  2020-04-28       Impact factor: 4.849

9.  Complete bilateral ophthalmoplegia with unilateral facial palsy in a child with anti-GQ1b syndrome.

Authors:  Hina Kauser; Puneet Jain; Suvasini Sharma; Satinder Aneja
Journal:  Indian J Pediatr       Date:  2014-07-05       Impact factor: 1.967

10.  Bickerstaff's encephalitis.

Authors:  Emma Horton; Sanjay Krishnamoorthy; Lucy Reynolds
Journal:  BMJ Case Rep       Date:  2014-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.